The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
Open accessAbstract
The major target of the neutralizing antibody response to infection by the human immunodeficiency virus type 1 (HIV-1) is the outer envelope glycoprotein, gp120. The spectrum of HIV-1 neutralization specificity is currently represented by monoclonal antibodies (mAbs) that can be divided broadly into five groups. We have studied the binding of these mAbs to functional oligomeric and soluble monomeric gp120 derived from the molecular clone of a cell line-adapted isolate of HIV-1, and compared these binding properties with virus neutralization. Binding of all mAbs except those reactive with the V3 loop was much weaker to oligomeric than to monomeric gp120. This reduction in binding to oligomeric gp120 was determined mostly by a slower relative rate of association, although the dissociation rate also had some influence on relative variation in mAb affinity. Virus neutralization correlated broadly with mAb binding to the oligomeric rather than to the monomeric form of gp120, and neutralization potency was related to the estimated association rate. Thus, with the exception of the hypervariable V3 loop, regions of HIV-1 gp120 with the potential to induce a neutralization response are likely to be poorly presented for antibody recognition on the surface of cell line-adapted virions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
Pathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., & Capon, D. J. (1987) · Cell · doi:10.1016/0092-8674(87)90524-1 · Cited by 828
Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3978-3988.1993 · Cited by 616
Self-citationSattentau, Q. J., & Moore, J. P. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.2.407 · Cited by 600
Self-citationPalker, T. J., Clark, M. E., Langlois, A. J., Matthews, T. J., Weinhold, K. J., Randall, R. R., Bolognesi, D. P., & Haynes, B. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.6.1932 · Cited by 532
The CD4 antigen: Physiological ligand and HIV receptor
Sattentau, Q. J., & Weiss, R. A. (1988) · Cell · doi:10.1016/0092-8674(88)90397-2 · Cited by 413
Self-citationOlshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.5701-5707.1990 · Cited by 405
Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.101-109.1995 · Cited by 401
Self-citationOligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl, P. L., Doms, R. W., & Moss, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.648 · Cited by 359
Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope Glycoprotein
Lasky, L. A., Groopman, J. E., Fennie, C. W., Benz, P. M., Capon, D. J., Dowbenko, D. J., Nakamura, G. R., Nunes, W. M., Renz, M. E., & Berman, P. W. (1986) · Science · doi:10.1126/science.3014647 · Cited by 353
Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-1
Javaherian, K., Langlois, A. J., LaRosa, G. J., Profy, A. T., Bolognesi, D. P., Herlihy, W. C., Putney, S. D., & Matthews, T. J. (1990) · Science · doi:10.1126/science.1703322 · Cited by 353
Sattentau, Q. J., Moore, J. P., Vignaux, F., Traincard, F., & Poignard, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7383-7393.1993 · Cited by 317
Self-citationA molecular clone of HTLV-III with biological activity
Fisher, A. G., Collalti, E., Ratner, L., Gallo, R. C., & Wong-Staal, F. (1985) · Nature · doi:10.1038/316262a0 · Cited by 316
Gorny, M. K., Conley, A. J., Karwowska, S., Buchbinder, A., Xu, J. Y., Emini, E. A., Koenig, S., & Zolla-Pazner, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7538-7542.1992 · Cited by 308
Variable and conserved neutralization antigens of human immunodeficiency virus
Weiss, R. A., Clapham, P. R., Weber, J. N., Dalgleish, A. G., Lasky, L. A., & Berman, P. W. (1986) · Nature · doi:10.1038/324572a0 · Cited by 298
Posner, M. R., Hideshima, T., Cannon, T., Mukherjee, M., Mayer, K. H., & Byrn, R. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.12.4325 · Cited by 261
Moore, J. P., Sattentau, Q. J., Wyatt, R., & Sodroski, J. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.469-484.1994 · Cited by 248
Self-citationThali, M., Olshevsky, U., Furman, C., Gabuzda, D., Posner, M., & Sodroski, J. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.6188-6193.1991 · Cited by 222
Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W., & Moss, B. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3015-3026.1994 · Cited by 215
Moore, J. P., & Ho, D. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.2.863-875.1993 · Cited by 208
Self-citationThali, M., Furman, C., Ho, D. D., Robinson, J., Tilley, S., Pinter, A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.9.5635-5641.1992 · Cited by 195
Risk of Human Immunodeficiency Virus (HIV-1) Infection Among Laboratory Workers
Weiss, S. H., Goedert, J. J., Gartner, S., Popovic, M., Waters, D., Markham, P., di Marzo Veronese, F., Gail, M. H., Barkley, W. E., Gibbons, J., et al. (1988) · Science · doi:10.1126/science.3336776 · Cited by 179
Sullivan, N., Thali, M., Furman, C., Ho, D. D., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3674-3679.1993 · Cited by 163
Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles
Weiss, C. D., Levy, J. A., & White, J. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5674-5677.1990 · Cited by 160
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV
Schawaller, M., Smith, G. E., Skehel, J. J., & Wiley, D. C. (1989) · Virology · doi:10.1016/0042-6822(89)90142-6 · Cited by 160
Fusion from without directed by human immunodeficiency virus particles
Clavel, F., & Charneau, P. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.1179-1185.1994 · Cited by 159
Apical localization of K+ channels in taste cells provides the basis for sour taste transduction.
Kinnamon, S. C., Dionne, V. E., & Beam, K. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.7023 · Cited by 159
Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.
Profy, A. T., Salinas, P. A., Eckler, L., Dunlop, N. M., Nara, P. L., & Putney, S. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.12.4641 · Cited by 124
Moore, J. P., Sattentau, Q. J., Yoshiyama, H., Thali, M., Charles, M., Sullivan, N. J., Poon, S. W., Fung, M. S. C., Traincard, F., & Pinkus, M. S. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6136-6151.1993 · Cited by 120
Self-citationTILLEY, S. A., Honnen, W. J., RACHO, M. E., Hilgartner, M. W., & Pinter, A. (1991) · Research in Virology · doi:10.1016/0923-2516(91)90010-z · Cited by 118
McKeating, J. A., Cordell, J. L., Dean, H. J., & Balfe, P. (1992) · Virology · doi:10.1016/0042-6822(92)90249-o · Cited by 97
Robinson, J. E., Holton, D. L., PACHECO-MORELL, S., Liu, J., & McMurdo, H. B. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.567 · Cited by 78
Gelderblom, H. R., Özel, M., Hausmann, E. H. S., Winkel, T., Pauli, G., & Koch, M. A. (1988) · Micron and Microscopica Acta · doi:10.1016/0739-6260(88)90039-1 · Cited by 70
Ohno, T., Terada, M., Yoneda, Y., Shea, K. W., CHAMBERS, R. F., Stroka, D., Nakamura, M., & Kufe, D. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10726 · Cited by 66
Doms, R. W., Earl, P. L., Chakrabarti, S., & Moss, B. (1990) · Journal of Virology · doi:10.1128/jvi.64.7.3537-3540.1990 · Cited by 46
Design and trials of AIDS vaccines
Sonigo, P., Girard, M. P., & Dormont, D. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90177-b · Cited by 15
Stern, T. L., Reitz, M. S., & Robert-Guroff, M. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1860-1867.1995 · Cited by 10
Cited by
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Self-citationA Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Self-citationScanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Metadata
- Authors
- Sattentau, Q. J., & Moore, J. P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-07-01
- Volume
- 182
- Issue
- 1
- Pages
- 185-196
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2131906141
- Cited by
- 334
- References
- 38
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.